Christopher J. Reading's most recent trade in U.S. Physical Therapy, Inc. was a trade of 20,250 Common Stock done . Disclosure was reported to the exchange on Feb. 24, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
U.S. Physical Therapy, Inc. | Christopher J. Reading | Director, Chairman of the Board and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 20,250 | 116,088 (0%) | 0% | 0 | Common Stock | |
U.S. Physical Therapy, Inc. | Christopher J. Reading | Director, Chairman of the Board and CEO | Sale of securities on an exchange or to another person at price $ 100.26 per share. | 30 May 2024 | 2,900 | 95,838 (0%) | 0% | 100.3 | 290,754 | Common Stock |
U.S. Physical Therapy, Inc. | Christopher J. Reading | Director, Chairman of the Board and CEO | Sale of securities on an exchange or to another person at price $ 102.13 per share. | 28 May 2024 | 1,100 | 99,738 (0%) | 0% | 102.1 | 112,343 | Common Stock |
U.S. Physical Therapy, Inc. | Christopher J. Reading | Director, Chairman of the Board and CEO | Sale of securities on an exchange or to another person at price $ 100.13 per share. | 28 May 2024 | 1,000 | 98,738 (0%) | 0% | 100.1 | 100,130 | Common Stock |
U.S. Physical Therapy, Inc. | Christopher J. Reading | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 16,200 | 100,838 (0%) | 0% | 0 | Common Stock | |
U.S. Physical Therapy, Inc. | Christopher J. Reading | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2023 | 10,000 | 84,638 (0%) | 0% | 0 | Common Stock | |
U.S. Physical Therapy, Inc. | Christopher J. Reading | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 05 Dec 2022 | 5,000 | 74,638 (0%) | 0% | 90 | 450,000 | Common Stock |
U.S. Physical Therapy, Inc. | Christopher J. Reading | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 90.01 per share. | 02 Dec 2022 | 10,000 | 79,638 (0%) | 0% | 90.0 | 900,100 | Common stock |
U.S. Physical Therapy, Inc. | Christopher J. Reading | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 20,000 | 89,638 (0%) | 0% | 0 | Common Stock | |
U.S. Physical Therapy, Inc. | Christopher J. Reading | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 93.89 per share. | 17 Dec 2021 | 12,000 | 69,638 (0%) | 0% | 93.9 | 1,126,680 | Common Stock |
U.S. Physical Therapy, Inc. | Christopher J. Reading | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 11,200 | 81,638 (0%) | 0% | 0 | Common Stock | |
U.S. Physical Therapy, Inc. | Christopher J. Reading | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 106.67 per share. | 04 Dec 2020 | 6,000 | 70,438 (0%) | 0% | 106.7 | 640,020 | Common Stock |